Screening of myelin-oligodendrocyte-glycoprotein (MOG) antibodies in a large prospective pediatric cohort with demyelinating syndromes or other encephalitis showed surprisingly high rate of positive results. The study showed implications on diagnostic and therapeutic strategies.(1)
- Armangue T, Olivé-Cirera G, Martínez-Hernandez E, Sepulveda M, Ruiz-Garcia R, Muñoz-Batista M, et al. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. The Lancet Neurology [Internet]. 2020 Feb 10 [cited 2020 Feb 16];0(0).
By Priv-Doz Dr Tim von Oertzen, FRCP, FEAN (on behalf of the e-communication board)